BriaCell Therapeutics Corporation (BCTX) Quote

Gets out now millions of offering shares at .69…12,325,000 common shares. Each common share was sold at an offering price of $0.69 per share, for gross proceeds of approximately $8.5 million,

BCTX..................................https://stockcharts.com/h-sc/ui?s=BCTX&p=W&b=5&g=0&id=p86431144783

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

Sorry. Wrong Board.

BriaCell Therapeutics Announces $8.5 Million Offering

aks yourself why no BP wanted to be a part of this. Plenty of time to notice?

BCTX..........................https://stockcharts.com/h-sc/ui?s=BCTX&p=W&b=5&g=0&id=p86431144783

I'm predicting an offering this week... Company needs cash. Under $1m currently

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer
Median overall survival of 15.6 months in Phase 2 Bria-IMT™ study patients treated in combination with immune checkpoint inhibitor
OS of 15.6 months compares favorably with 6.7-9.3 months reported for similar patients in the literature
Ongoing Phase 3 study investigating Bria-IMT™ in similar metastatic breast cancer population
No drug related discontinuations to date
PHILADELPHIA and VANCOUVER, British Columbia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce positive overall survival data of its Phase 2 clinical study of Bria-IMT™ in combination with an immune check point inhibitor (CPI) in late stage metastatic breast cancer.
https://www.otcmarkets.com/stock/BCTX/news/story?e&id=2978177

Don’t blink

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer

Good news and it goes lower again,,,lol

BCTX new 52 week low

BCTX new 52 week low

BCTX new 52 week low

BCTX under $2

BCTX new 52 week low

BCTX new 52 week low

BCTX. Under $3

$BCTX Shows “Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer”

Press Release: https://bit.ly/4aJmAoc

$BCTX #CancerTreatment #Innovation

Does anyone have information about the stock spinoff that occurred last year with this company? I have 600 shares of the spinoff security with 0 value and has remained that way since the spinoff. Thanks…

BCTX new 52 lo

BCTX new 52 lo

BCTX 10Q due March 13

BCTX new 52 week low

BCTX new 52 week low

$BCTX is thrilled to announce a new remarkable responder in our Phase 2 study of the Bria-IMT™ combination regimen. https://finance.yahoo.com/news/briacell-records-responder-remarkable-improvement-120000404.html

Good news today. I took a entry

BCTX new 52 week low

2023 Anticipated Milestones, please?

$BCTX $15 Price Target

Zacks Small-Cap Research just released a new report on BriaCell Therapeutics Corp. (Nasdaq: BCTX) with a $15 price target.

Read the full report here: https://scr.zacks.com/.../BCTX-Posters.../default.aspx

#Stocks #StocksToWatch #StockMarket

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) was featured in an article on Seeking Alpha
Discover more about this #BioTech company here: https://bit.ly/3DoEbUc
BriaCell Therapeutics: Fast-Tracking High-Potential Breast Cancer Immunotherapy
#Stocks #StocksToWatch

Strange stock, but I've loved having it the past couple of years. I've mostly day traded, as there was a pretty good pattern last year, of early drops and late charges, and vice versa. I did end up getting stuck at around $10 so have been holding a lot at that level. Hopefully it runs again and I can keep chipping away at my mortgage because of the fancy researchers in Vancouver. Best of luck, all!

Yep, I'm still here. She's getting ready to burst! Low float/high short interest, Fast track approval and now up on big volume. Gonna get interesting!

Under $4 by end of month

BriaCell Therapeutics Price Target Announced at $25.00/Share by HC Wainwright & Co.

BriaCell Reports Received FDA Fast Track Approval For Its Targeted Breast Cancer Immunotherapy

BCTX

I'm still here....wait til you see what happens this week

We will dance!

Closed above resistance of $10.50....We dance on Monday

Low float/high short interest. Setting up for big run

$BCTX BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer. More information is available at https://briacell.com/.

$BCTX announces the addition of Suzanne Ostrand-Rosenberg, Ph.D. to its Scientific Advisory Board.

Dr. Ostrand-Rosenberg has more than 40 years of experience leading investigations focused on the immune system’s response to cancer. She is currently the Robert & Jane Meyerhoff Professor of Biochemistry, Emeritus, and Professor of Biological Sciences, Emeritus, University of Maryland Baltimore County, Baltimore, MD, and has been working with the University since 1977. She was also appointed as the Adjunct Professor of Pathology, Huntsman Cancer Institute (HCI), University of Utah, Salt Lake City, UT, in 2018. https://finance.yahoo.com/news/briacell-adds-pioneering-immunologist-cancer-130000276.html

$BCTX has added Pioneering Immunologist and Cancer Immunotherapy Expert, Suzanne Ostrand-Rosenberg, Ph.D., to its Scientific Advisory Board!

Click here for a bio and to learn what she's bringing to the BriaCell team!

https://yhoo.it/3kbmmhX

Easy Money for more $ZOM shares $BCTX thanks to @MrZackMorris for the tip in his Reddit community.. called this out last month on my Instagram big profits.. shorts are still all over this.. squeeze is to be prepared for.. get in profit big and get out .. October is #BreastCancerAwarenessMonth also load on $ZOM ?? it acquired Pulse Vet

$BCTX thanks to @MrZackMorris for the tip in his Reddit community.. called this out last month on my Instagram big profits.. shorts are all over this now.. squeeze is to be prepared for.. get in profit big and get out .. October is #BreastCancerAwarenessMonth also load on $ZOM 💎 pic.twitter.com/wJVS4lZydq— BL3 (@SellingStrikes) October 3, 2021

(Nasdaq: BCTX, BCTXW) (TSX-V: BCT) CEO highlights key achievements of the company including recent collaboration with ImaginAb https://yhoo.it/3CDPzc7

BriaCell Therapeutics Corp. (Nasdaq: $BCTX, $BCTXW) (TSX-V:BCT) News Alert https://yhoo.it/3gmjQ6A #stocks #medical #stockstowatch

BCTX



https://schrts.co/gJajQPrD

MarketsandMarkets 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition: June 28-30, 2021
Dr. Williams will be speaking at the scientific conference at 11:30am ET on June 29, 2021.
The topic is “Personalized, off-the-shelf cellular immunotherapy for cancer”.
A copy of the presentation will be posted here: https://briacell.com/novel-technology/scientific-publications/.
For additional information on the conference and the speaker, please visit:
https://events.marketsandmarkets.com/4th-annual-next-gen-immuno-oncology-virtual-congress-us-edition/speakers

Separately, BriaCell has recently appointed Miguel A. Lopez-Lago, Ph.D. as Senior Director, Research and Development. Since 2000, Dr. Lopez-Lago has been working as a cancer scientist at Memorial Sloan-Kettering Cancer Center, New York (MSKCC). Specifically, he has investigated various aspects of tumor biology, including the development of targeted therapies for Mesothelioma and the characterization of the biological mechanisms underlying cancer metastasis. More recently, Dr. Lopez-Lago has been interested in the study of the tumor immune-microenvironment and in the development of immunotherapies for thoracic cancers using chimeric antigen receptor (CAR) T cell technologies. Since 2013, Dr. Lopez-Lago has been working as Senior Research Scientist at MSKCC. Dr. Lopez-Lago received his Bachelor of Science in Bio-Sciences and his doctorate in Molecular Biology from Santiago of Compostela University, Spain.

About BriaCell Therapeutics Corp.

BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.

For additional information on BriaCell, please visit: https://briacell.com/.

https://www.globenewswire.com/en/news-release/2021/05/11/2226965/0/en/BriaCell-to-Participate-at-Upcoming-Conferences-and-Appoints-Senior-R-D-Director.html

https://www.globenewswire.com/news-release/2021/06/16/2248189/0/en/BriaCell-Therapeutics-Expands-Breast-Cancer-Platform-Technology-into-Prostate-Melanoma-and-Lung-Cancers.html

https://finance.yahoo.com/news/briacell-reports-12-0-months-111200861.html